GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 92 filers reported holding GALENA BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $165,000 | -25.0% | 471,657 | 0.0% | 0.00% | – |
| Q2 2016 | $220,000 | -65.7% | 471,657 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $641,000 | -7.5% | 471,657 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $693,000 | -7.0% | 471,657 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $745,000 | -7.1% | 471,657 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $802,000 | +262.9% | 471,657 | +265.5% | 0.00% | – |
| Q1 2015 | $221,000 | 0.0% | 129,057 | 0.0% | 0.00% | – |
| Q4 2014 | $221,000 | -16.9% | 129,057 | 0.0% | 0.00% | – |
| Q3 2014 | $266,000 | -32.7% | 129,057 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $395,000 | +32.6% | 129,057 | 0.0% | 0.00% | – |
| Q1 2014 | $298,000 | -43.2% | 129,057 | 0.0% | 0.00% | -100.0% |
| Q4 2013 | $525,000 | +74.4% | 129,057 | -2.7% | 0.00% | 0.0% |
| Q3 2013 | $301,000 | +4.9% | 132,657 | +2.8% | 0.00% | 0.0% |
| Q2 2013 | $287,000 | – | 129,057 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,446,469 | $13,616,000 | 2.03% |
| Harbour Capital Advisors, LLC | 78,450 | $196,000 | 0.19% |
| SABBY MANAGEMENT, LLC | 708,089 | $1,770,000 | 0.10% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 174,600 | $437,000 | 0.07% |
| Alyeska Investment Group, L.P. | 530,000 | $1,950,000 | 0.05% |
| HIGHLAND CAPITAL MANAGEMENT LP | 528,027 | $1,320,000 | 0.05% |
| KMS FINANCIAL SERVICES, INC | 118,042 | $295,000 | 0.05% |
| Quantitative Investment Management, LLC | 348,500 | $871,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 538,100 | $1,345,000 | 0.04% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $74,000 | 0.04% |